Related Experiment Video
Updated: Jun 23, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
1Department of Psychiatry and Behavioral Science, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY, USA.
Objective:
The authors report three cases of neuroleptic malignant syndrome (NMS) induced by atypical antipsychotics (olanzapine and clozapine) which showed classic features of NMS including muscular rigidity and prominent fever.
Method:
Case reports.
Results:
A 66-year-old man with dementia and alcohol abuse developed NMS while on olanzapine for agitation and combativeness. A 62-year-old man with schizophrenia developed NMS 6 days after starting clozapine. A 43-year-old man with bipolar disorder developed NMS 14 days after starting clozapine. All three cases showed classic features of NMS including muscular rigidity and fever. Resolution of fever and muscular rigidity occurred within 72 hours with discontinuation of neuroleptics, supportive care, and lorazepam. The NMS rating scale reflected daily clinical improvement.
Conclusion:
Classic NMS characterized by muscular rigidity and prominent fever may occur with atypical neuroleptics. Our cases suggest recovery from NMS associated with atypical neuroleptics may be hastened by lorazepam, as was previously reported for NMS from typical neuroleptics. Also, the NMS rating scale was sensitive to clinical improvement.
Insights
Atypical antipsychotics like olanzapine and clozapine can cause neuroleptic malignant syndrome (NMS), presenting with rigidity and fever. Early intervention with lorazepam and supportive care aids recovery from NMS.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Neuroleptic malignant syndrome (NMS) is a rare but serious adverse reaction to antipsychotic medications.
- Atypical antipsychotics are increasingly used, necessitating an understanding of their associated risks.
Observation:
- Three case reports detail patients developing NMS while on atypical antipsychotics (olanzapine, clozapine).
- Clinical presentation included classic NMS features: muscular rigidity and prominent fever.
- Onset varied, occurring within 6 to 14 days of initiating clozapine or olanzapine therapy.
Findings:
- Discontinuation of the offending neuroleptic, supportive care, and administration of lorazepam led to resolution of NMS symptoms within 72 hours.
- The Neuroleptic Malignant Syndrome rating scale demonstrated sensitivity to daily clinical improvement.
- Lorazepam may expedite recovery from NMS induced by atypical antipsychotics, similar to its effect with typical antipsychotics.
Implications:
- Clinicians should be vigilant for NMS when prescribing atypical antipsychotics.
- Prompt recognition and management, including lorazepam, can improve patient outcomes.
- Further research into the role of lorazepam in atypical antipsychotic-induced NMS is warranted.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Mania and Antimanic Drugs: Overview
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...